UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Relationship between intestinal flora structure and metabolite analysis and immunotherapy efficacy in Chinese NSCLC patients

Thoracic cancer, 2020-06, Vol.11 (6), p.1621-1632

2020

Volltextzugriff (PDF)

Clinical diagnosis and treatment of immune checkpoint inhibitor‐associated pneumonitis

Thoracic cancer, 2020-01, Vol.11 (1), p.191-197

2020

Volltextzugriff (PDF)

Pyrotinib‐associated acute kidney injury: A case report

Cancer innovation (Print), 2022-12, Vol.1 (4), p.344-347

2022

Volltextzugriff (PDF)

Relationship between the efficacy of immunotherapy and characteristics of specific tumor mutation genes in non‐small cell lung cancer patients

Thoracic cancer, 2020-06, Vol.11 (6), p.1647-1654

2020

Volltextzugriff (PDF)

Savolitinib versus crizotinib for treating MET positive non‐small cell lung cancer

Thoracic cancer, 2023-05, Vol.14 (13), p.1162-1170

2023

Volltextzugriff (PDF)

Opportunistic infections complicating immunotherapy for non‐small cell lung cancer

Thoracic cancer, 2020-06, Vol.11 (6), p.1689-1694

2020

Volltextzugriff (PDF)

Prognostic biomarkers and immune cell infiltration characteristics in small cell lung cancer

Cancer pathogenesis and therapy, 2023-01, Vol.1 (1), p.18-24

2023

Volltextzugriff (PDF)

Clinical recommendations on diagnosis and treatment of immune checkpoint inhibitor‐induced renal immune‐related adverse events

Thoracic cancer, 2020-06, Vol.11 (6), p.1746-1751

2020

Volltextzugriff (PDF)

Management of anlotinib‐related adverse events in patients with advanced non‐small cell lung cancer: Experiences in ALTER‐0303

Thoracic cancer, 2019-03, Vol.10 (3), p.551-556

2019

Volltextzugriff (PDF)

Abivertinib in patients with T790M‐positive advanced NSCLC and its subsequent treatment with osimertinib

Thoracic cancer, 2020-03, Vol.11 (3), p.594-602

2020

Volltextzugriff (PDF)

The development of a tumor‐associated autoantibodies panel to predict clinical outcomes for immune checkpoint inhibitor‐based treatment in patients with advanced non‐small‐cell lung cancer

Thoracic cancer, 2023-02, Vol.14 (5), p.497-505

2023

Volltextzugriff (PDF)

Histologic transformation of lung cancer during pembrolizumab therapy: A case report

Thoracic cancer, 2020-03, Vol.11 (3), p.793-796

2020

Volltextzugriff (PDF)

Management of immune checkpoint inhibitor‐related dermatologic adverse events

Thoracic cancer, 2020-02, Vol.11 (2), p.488-492

2020

Volltextzugriff (PDF)

Clinical characteristics and prognostic model for extensive‐stage small cell lung cancer: A retrospective study over an 8‐year period

Thoracic cancer, 2022-02, Vol.13 (4), p.539-548

2022

Volltextzugriff (PDF)

Clinical diagnosis and treatment recommendations for immune checkpoint inhibitor‐related hematological adverse events

Thoracic cancer, 2020-03, Vol.11 (3), p.799-804

2020

Volltextzugriff (PDF)

Genomic characteristics of driver genes in Chinese patients with non‐small cell lung cancer

Thoracic cancer, 2021-02, Vol.12 (3), p.357-363

2021

Volltextzugriff (PDF)

A phase III, randomized, double-blind, controlled trial of carboxyamidotriazole plus chemotherapy for the treatment of advanced non-small cell lung cancer

Therapeutic advances in medical oncology, 2020, Vol.12, p.1758835920965849-1758835920965849

2020

Volltextzugriff (PDF)

Pulmonary and Skeletal Infection of Mycobacterium kansasii

American journal of respiratory and critical care medicine, 2020-10, Vol.202 (8), p.1169-1170

2020

Volltextzugriff (PDF)

Analysis of cytokines in bronchoalveolar lavage fluid in patients with checkpoint inhibitor pneumonitis and pulmonary infection: A case–control study

Thoracic cancer, 2023-07, Vol.14 (21), p.2038-2044

2023

Volltextzugriff (PDF)

Single‐center study to determine the safety and efficacy of CT‐707 in Chinese patients with advanced anaplastic lymphoma kinase‐rearranged non‐small‐cell lung cancer

Thoracic cancer, 2020-05, Vol.11 (5), p.1216-1223

2020

Volltextzugriff (PDF)

Successful treatment of pulmonary inflammatory myofibroblastic tumor with platinum‐pemetrexed: The first report of two cases

Thoracic cancer, 2020-08, Vol.11 (8), p.2339-2342

2020

Volltextzugriff (PDF)

Clinical diagnosis and treatment recommendations for ocular toxicities of targeted therapy and immune checkpoint inhibitor therapy

Thoracic cancer, 2020-03, Vol.11 (3), p.810-818

2020

Volltextzugriff (PDF)

Clinical manifestation and management of immune checkpoint inhibitor‐associated cardiotoxicity

Thoracic cancer, 2020-02, Vol.11 (2), p.475-480

2020

Volltextzugriff (PDF)

Leptomeningeal enhancement in magnetic resonance imaging predicts poor prognosis in lung adenocarcinoma patients with leptomeningeal metastasis

Thoracic cancer, 2022-04, Vol.13 (7), p.1059-1066

2022

Volltextzugriff (PDF)

Recommendation for the diagnosis and management of immune checkpoint inhibitor related infections

Thoracic cancer, 2020-03, Vol.11 (3), p.805-809

2020

Volltextzugriff (PDF)

1 – 25 von 264

Suche als RSS-Feed

Aktive Filter

KollektionConnected Ingenta

ThemaAnimals

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(225)
Mit Volltextzugriff
(229)

Publikationsform

Sprache

Englisch
(257)
Chinesisch
(4)

Erscheinungsjahr

n.n

Thema

Science & Technology
(176)
Life Sciences & Biomedicine
(113)
Humans
(60)
Technology
(46)
Oncology
(45)
Respiratory System
(34)
Physical Sciences
(32)
Lung Cancer
(28)
Materials Science
(28)
Patients
(28)
Materials Science, Multidisciplinary
(25)
Chemistry
(24)
Engineering
(24)
Male
(24)
Prognosis
(23)
Original
(22)
Female
(21)
Middle Aged
(19)
Mutation
(18)
Cancer Therapies
(17)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Relationship between intestinal flora structure and metabolite analysis and immunotherapy efficacy in Chinese NSCLC patients

Clinical diagnosis and treatment of immune checkpoint inhibitor‐associated pneumonitis

Pyrotinib‐associated acute kidney injury: A case report

Relationship between the efficacy of immunotherapy and characteristics of specific tumor mutation genes in non‐small cell lung cancer patients

Savolitinib versus crizotinib for treating MET positive non‐small cell lung cancer

Opportunistic infections complicating immunotherapy for non‐small cell lung cancer

Prognostic biomarkers and immune cell infiltration characteristics in small cell lung cancer

Clinical recommendations on diagnosis and treatment of immune checkpoint inhibitor‐induced renal immune‐related adverse events

Management of anlotinib‐related adverse events in patients with advanced non‐small cell lung cancer: Experiences in ALTER‐0303

Abivertinib in patients with T790M‐positive advanced NSCLC and its subsequent treatment with osimertinib

The development of a tumor‐associated autoantibodies panel to predict clinical outcomes for immune checkpoint inhibitor‐based treatment in patients with advanced non‐small‐cell lung cancer

Histologic transformation of lung cancer during pembrolizumab therapy: A case report

Management of immune checkpoint inhibitor‐related dermatologic adverse events

Clinical characteristics and prognostic model for extensive‐stage small cell lung cancer: A retrospective study over an 8‐year period

Clinical diagnosis and treatment recommendations for immune checkpoint inhibitor‐related hematological adverse events

Genomic characteristics of driver genes in Chinese patients with non‐small cell lung cancer

A phase III, randomized, double-blind, controlled trial of carboxyamidotriazole plus chemotherapy for the treatment of advanced non-small cell lung cancer

Pulmonary and Skeletal Infection of Mycobacterium kansasii

Analysis of cytokines in bronchoalveolar lavage fluid in patients with checkpoint inhibitor pneumonitis and pulmonary infection: A case–control study

Single‐center study to determine the safety and efficacy of CT‐707 in Chinese patients with advanced anaplastic lymphoma kinase‐rearranged non‐small‐cell lung cancer

Successful treatment of pulmonary inflammatory myofibroblastic tumor with platinum‐pemetrexed: The first report of two cases

Clinical diagnosis and treatment recommendations for ocular toxicities of targeted therapy and immune checkpoint inhibitor therapy

Clinical manifestation and management of immune checkpoint inhibitor‐associated cardiotoxicity

Leptomeningeal enhancement in magnetic resonance imaging predicts poor prognosis in lung adenocarcinoma patients with leptomeningeal metastasis

Recommendation for the diagnosis and management of immune checkpoint inhibitor related infections

Aktive Filter

Suchergebnisse filtern